Nation Jan 13

Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections.

Health Dec 23

The Food and Drug Administration authorization of Merck's molnupiravir comes one day after the agency cleared a competing drug from Pfizer.

Health Dec 22

The long-awaited milestone comes as U.S. cases, hospitalizations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.

Health Dec 19

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they’ve used to fight infections are unlikely to work against the…

Health Dec 16

Earlier this year the FDA stopped enforcing the in-person dispending requirement because of the pandemic. Under Thursday's decision the agency will permanently drop the rule.

Politics Dec 14

President Joe Biden’s pick to lead the Food and Drug Administration deftly parried questions on crises ranging from the COVID pandemic to the opioid epidemic.

Health Dec 14

The company also confirmed Tuesday that the pill delivered on promising early results in reducing COVID-19 hospitalizations and deaths.

Nation Dec 09

The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination.

Health Dec 08

The drug could benefit cancer patients, organ transplant recipients and people with severe allergies to vaccinations.

Health Nov 30

U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients.